PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Current SP appreciation, page-121

  1. 249 Posts.
    lightbulb Created with Sketch. 20
    hi cabe
    reading yours and mozzarcs prior post highlights the investors quandary.(not being presumptive about eithers' investment strategies)
    does the "astute" investor have a sensible balanced portfolio or with unshakeable logic put all on the nose for something that can slingshot them to the happy position ?
    A foot in both camps is ideal but then the GFC didn't discriminate and it was only the rate of recovery that restored colour to the public companies first blue,then green etc.
    If there is absolute conviction about the stocks trajectory which to choose ?
    we only die at the end anyway?
    more than just curious gentlemen(itself an assumption)
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.